Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Consumer Health in Israel

Published by Euromonitor International Product code 973647
Published Content info 110 Pages
Delivery time: 1-2 business days
Price
Back to Top
Consumer Health in Israel
Published: November 23, 2020 Content info: 110 Pages
Description

Consumer health is expected to see slower current value growth in 2020 than was seen the previous year. One of the factors dictating growth in this year is expected to be COVID-19. As news about the virus emerged in the country, consumers began panic-buying at the start of quarter two of 2020, stockpiling certain consumer health products, such as analgesics, cough, cold and allergy (hay fever) remedies, immunity-boosting vitamins and dietary supplements and eye care, for fear of shortages. This...

Euromonitor International's Consumer Health in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
Product Code: CHIS

TABLE OF CONTENTS

List OF CONTENTS AND TABLES

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 2 Life Expectancy at Birth 2015-2020

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2015-2020
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 7 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 8 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

    • Summary 1 Research Sources

KEY DATA FINDINGS

2020 IMPACT

Consumers stockpile analgesics, but are likely to finish stockpiles first thereby limiting growth overall in 2020

E-commerce sales grow due to COVID-19, while stressful and busy lifestyles drive growth of analgesics

Teva Pharmaceutical Industries continues to lead, while consumers stay loyal to GSK's ibuprofen brands and private label continues to gain share in 2020

RECOVERY AND OPPORTUNITIES

Steady growth expected thanks to being a familiar category in households

Consumers continue to switch from system analgesics to topical formats in order to avoid unnecessary chemicals

New chemists/pharmacies retail outlets likely to stimulate price competition and growth

CATEGORY DATA

  • Table 11 Sales of Analgesics by Category: Value 2015-2020
  • Table 12 Sales of Analgesics by Category: % Value Growth 2015-2020
  • Table 13 NBO Company Shares of Analgesics: % Value 2016-2020
  • Table 14 LBN Brand Shares of Analgesics: % Value 2017-2020
  • Table 15 Forecast Sales of Analgesics by Category: Value 2020-2025
  • Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Stockpiling in March and April is offset by slowdown as COVID-19 restrictions are eased

Growth limited by the lack of flu cases, mainly as a result of COVID-19

Teva Pharmaceutical Industries continues to lead, while GSK and Dexcel Pharma compete for second place and private label gains share in 2020

RECOVERY AND OPPORTUNITIES

Stable growth forecast, driven by combination products - cough, cold and allergy (hay fever) remedies

Growth in nasal sprays as saltwater sprays largely used for children

Growth to slow as winters return to more normal patterns

CATEGORY DATA

  • Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
  • Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
  • Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
  • Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Growth negated thanks to travel ban and consumers preparing meals at home

Strong competition from medical devices

GSK Consumer Healthcare increases its lead but face increasing competition from medical devices, prescription medication, and lifestyle changes

RECOVERY AND OPPORTUNITIES

Rebound expected from 2021 but trends in consumer eating habits will have conflicting effects on digestive remedies

Indigestion and heartburn remedies set to continue suffering from a shift to prescription medication

Ageing population supports growth

CATEGORY DATA

  • Table 23 Sales of Digestive Remedies by Category: Value 2015-2020
  • Table 24 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
  • Table 25 NBO Company Shares of Digestive Remedies: % Value 2016-2020
  • Table 26 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
  • Table 27 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
  • Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Opposing forces impact dermatologicals as a result of the pandemic in 2020

Strong competition from medical devices and cosmetic products limits growth of dermatologicals

Perrigo Israel Pharmaceuticals maintains its lead, while Bayer Israel gains share in 2020

RECOVERY AND OPPORTUNITIES

High birth rate set to contribute to growth over the forecast period

Medicated shampoos boosted by the entry of Head & Shoulders

Hair loss treatments expensive resulting in a shift to lower-priced cosmetic products

CATEGORY DATA

  • Table 29 Sales of Dermatologicals by Category: Value 2015-2020
  • Table 30 Sales of Dermatologicals by Category: % Value Growth 2015-2020
  • Table 31 NBO Company Shares of Dermatologicals: % Value 2016-2020
  • Table 32 LBN Brand Shares of Dermatologicals: % Value 2017-2020
  • Table 33 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
  • Table 34 Forecast Sales of Dermatologicals by Category: Value 2020-2025
  • Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Several factors related to COVID-19 contribute to growth in 2020

Increasing growth as regulation of smokeless tobacco and e-vapour products rise

Nicotinell - virtually the only brand present

RECOVERY AND OPPORTUNITIES

The shrinking potential user base set to limit growth

HMO's offer alternatives to NRT smoking cessation aids

NRT lozenges unpopular

CATEGORY INDICATORS

  • Table 36 Number of Smokers by Gender 2015-2020

CATEGORY DATA

  • Table 37 Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
  • Table 38 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
  • Table 39 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2016-2020
  • Table 40 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2017-2020
  • Table 41 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
  • Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

More consumers have sleep problems due to COVID-19 and seek help

Consumers increasingly consult their doctors in order to avoid the potential side effects of sleep aids

Neopharm Import (Israel) 1966 continues to lead but faces increasing competition, and private label continues to lose share in 2020

RECOVERY AND OPPORTUNITIES

Sleep aids likely to grow as consumers more willing to use medication for insomnia but countered by consumers' suspicion of side-effects

Hectic lifestyles encourage more consumers to turn to sleep aids

Herbal/traditional sleep aids increasingly popular as consumers seek natural remedies

CATEGORY DATA

  • Table 43 Sales of Sleep Aids: Value 2015-2020
  • Table 44 Sales of Sleep Aids: % Value Growth 2015-2020
  • Table 45 NBO Company Shares of Sleep Aids: % Value 2016-2020
  • Table 46 LBN Brand Shares of Sleep Aids: % Value 2017-2020
  • Table 47 Forecast Sales of Sleep Aids: Value 2020-2025
  • Table 48 Forecast Sales of Sleep Aids: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

More time spent on screens for work and entertainment contributes to growth while personal hygiene decreases incidence of eye infections in 2020

Shift to higher-priced products

Lapidot Medical Import and Marketing extends its lead

RECOVERY AND OPPORTUNITIES

Increasing screen use and air-conditioned offices leads to ongoing demand for eye care

Manufacturers shift to medical devices to gain greater flexibility

Private label relatively strong in allergy eye care

CATEGORY DATA

  • Table 49 Sales of Eye Care by Category: Value 2015-2020
  • Table 50 Sales of Eye Care by Category: % Value Growth 2015-2020
  • Table 51 NBO Company Shares of Eye Care: % Value 2016-2020
  • Table 52 LBN Brand Shares of Eye Care: % Value 2017-2020
  • Table 53 Forecast Sales of Eye Care by Category: Value 2020-2025
  • Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Slower growth rate from COVID-19 as consumers spend more time at home

Growing variety of printed plasters

Chemipal extends its lead but strong growth for private label threatens its position

RECOVERY AND OPPORTUNITIES

Growth expected to be driven by the health and wellness trend

Little innovation in wound care leads to low brand loyalty

Consumers seeking value-for-money likely to support private label

CATEGORY DATA

  • Table 55 Sales of Wound Care by Category: Value 2015-2020
  • Table 56 Sales of Wound Care by Category: % Value Growth 2015-2020
  • Table 57 NBO Company Shares of Wound Care: % Value 2016-2020
  • Table 58 LBN Brand Shares of Wound Care: % Value 2017-2020
  • Table 59 Forecast Sales of Wound Care by Category: Value 2020-2025
  • Table 60 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Vitamin C sees growth thanks to the pandemic, followed by vitamin D

E-commerce boosted by the pandemic in 2020

Ta'am Teva-Altman General Partnership maintains its lead and Ambrosia Ltd Solgar Israel loses share

RECOVERY AND OPPORTUNITIES

Solid growth as some consumers maintain the habit of taking vitamins

Innovation increasingly focuses on vitamin absorption to position vitamins as effective products

The rising popularity of sports activities likely to drive growth of vitamins

CATEGORY DATA

  • Table 61 Sales of Vitamins by Category: Value 2015-2020
  • Table 62 Sales of Vitamins by Category: % Value Growth 2015-2020
  • Table 63 Sales of Multivitamins by Positioning: % Value 2015-2020
  • Table 64 NBO Company Shares of Vitamins: % Value 2016-2020
  • Table 65 LBN Brand Shares of Vitamins: % Value 2017-2020
  • Table 66 Forecast Sales of Vitamins by Category: Value 2020-2025
  • Table 67 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Immune boosting dietary supplements ensures stronger growth in 2020 with some shortages due to stockpiling

Shift to e-commerce intensifies as consumers avoid shops due to COVID-19

Ta'am Teva-Altman General Partnership maintains its lead, while Ambrosia Ltd Solgar Israel remains in second place despite losing share

RECOVERY AND OPPORTUNITIES

Strong growth for dietary supplements, especially probiotics over forecast period

Dietary supplements expected to be driven by successive trends over forecast period

Growing demand for combination dietary supplements

CATEGORY DATA

  • Table 68 Sales of Dietary Supplements by Category: Value 2015-2020
  • Table 69 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
  • Table 70 Sales of Dietary Supplements by Positioning: % Value 2015-2020
  • Table 71 NBO Company Shares of Dietary Supplements: % Value 2016-2020
  • Table 72 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
  • Table 73 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
  • Table 74 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Weight loss supplements drives growth due to increased snacking during lockdown in 2020

Herbalife International of Israel (1990) makes dramatic progress, while Oriental Secrets loses share due to the dramatic declines in slimming teas in 2020

Direct selling retains majority share and e-commerce gains value share in 2020

RECOVERY AND OPPORTUNITIES

Supplement nutrition drinks expected to continue to drive growth

Alternative diets to remain popular

Meal replacement in decline due to growing awareness of nutrition

CATEGORY DATA

  • Table 75 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
  • Table 76 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
  • Table 77 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
  • Table 78 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
  • Table 79 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
  • Table 80 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Active lifestyles contribute to growth, with a move seen to e-commerce

Sports nutrition becomes mainstream, continuing to extend its reach from just professional sports people in 2020

Meditrend continues to lead in 2020, while Setty Sport continues to lose share following bribery scandal

RECOVERY AND OPPORTUNITIES

Rapid growth thanks to growing awareness of the importance of protein consumption over the forecast period

Availability set to improve

Local regulation hinders stronger growth over the forecast period

CATEGORY DATA

  • Table 81 Sales of Sports Nutrition by Category: Value 2015-2020
  • Table 82 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
  • Table 83 NBO Company Shares of Sports Nutrition: % Value 2016-2020
  • Table 84 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
  • Table 85 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
  • Table 86 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Growth rate relatively stable despite COVID-19

A holistic approach to health contributes to growth in 2020

Ta'am Teva-Altman General Partnership retains its lead and private label extends its share in 2020

RECOVERY AND OPPORTUNITIES

Herbal/traditional paediatric dietary supplements likely to drive growth as parents seek to ensure balanced nutrition for their children

Herbal/traditional sleep aids increasingly popular due to concerns about potential side effects of standard versions

Herbal/traditional topical analgesics likely to decline as consumers do not see the need for more natural products

CATEGORY DATA

  • Table 87 Sales of Herbal/Traditional Products by Category: Value 2015-2020
  • Table 88 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
  • Table 89 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
  • Table 90 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
  • Table 91 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
  • Table 92 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Growth somewhat curtailed in 2020 as data regarding the manifestation of COVID-19 in children becomes available

Paediatric analgesics increasingly used to treat children's fevers

Teva Pharmaceutical Industries maintains its lead and Ta'am Teva-Altman General Partnership retains its second place, while private label increases its share in 2020

RECOVERY AND OPPORTUNITIES

Slower but still solid growth expected for the forecast period

Hectic lifestyles expected to encourage parents to provide paediatric vitamins and dietary supplements to their children

Shift to more natural nasal sprays in paediatric cough/cold remedies which are gentler on children's skin

CATEGORY DATA

  • Table 93 Sales of Paediatric Consumer Health by Category: Value 2015-2020
  • Table 94 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
  • Table 95 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
  • Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
  • Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
  • Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
  • Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
Back to Top